Mexican researchers develop antibiotics from venom and peppers

Scientists at the National Autonomous University of Mexico have created three new antibiotics using compounds extracted from scorpion venom and habanero peppers. The effort targets tuberculosis and other bacteria that have grown resistant to current treatments.

Researchers from the National Autonomous University of Mexico identified fresh approaches to fighting bacterial resistance. They produced three antibiotics drawn directly from scorpion venom and habanero peppers.

관련 기사

Lab illustration of madecassic acid from Centella skincare inhibiting drug-resistant E. coli bacteria.
AI에 의해 생성된 이미지

Study finds madecassic acid, a Centella compound used in skincare, can inhibit drug-resistant E. coli in lab tests

AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨

Researchers at the University of Kent, working with University College London, report that madecassic acid—a compound derived from the medicinal herb Centella asiatica and widely used in skincare—can inhibit the growth of antibiotic-resistant E. coli by targeting a bacterial respiratory system not found in humans or other animals.

Scientists at the Weizmann Institute of Science in Israel have modified tobacco plants to produce five powerful psychedelic compounds typically found in mushrooms, plants, and toads. The technique uses temporary genetic changes to create a sustainable source for research and potential medicines. Experts say this could simplify production compared to chemical synthesis or harvesting from nature.

AI에 의해 보고됨

Researchers at Tokyo University of Science have discovered that combining common plant compounds from mint, eucalyptus, and chili peppers dramatically enhances their anti-inflammatory effects in immune cells. Certain pairings amplified the response several hundred-fold compared to individual use. The findings, published in the journal Nutrients, suggest potential for new dietary approaches to combat chronic inflammation.

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부